Position in EOLS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$112,518
-$87,668 QoQ
Shares Held
16,213
+13.4% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#88
of 157 holders
Holding Since
Mar 2024
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026INCEPTIONR LLC holds $4,209,930 across 8 Drug Manufacturers - Specialty & Generic names. EOLS ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
7,910 | $1,333,151 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
14,757 | $686,348 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
4,868 | $540,055 | |
| 4 | PRGO |
PERRIGO Co plc
|
51,202 | $531,988 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
5,693 | $471,266 | |
| 6 | LQDA |
Liquidia Corp
|
4,871 | $388,364 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
14,624 | $146,240 | |
| 8 | EOLS |
Evolus, Inc.
This page
|
16,213 | $112,518 |
All Filings in EOLS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $112,518 | 16,213 | Shares | Sole | 2026-08-11 | |
| 2024-03-31 | $200,186 | 14,299 | Shares | Sole | 2024-05-09 | |
| No filing history on record for this holder in this stock. | ||||||